binding affinity News and Research

RSS
Fusogenicity and resistance of SARS-CoV-2 B.1.1.7 and B.1.351 compared to D614G

Fusogenicity and resistance of SARS-CoV-2 B.1.1.7 and B.1.351 compared to D614G

Role of traditional medicine against SARS-CoV-2

Role of traditional medicine against SARS-CoV-2

New Astra-Zeneca B.1.351 vaccine AZD2816 strongly immunogenic against multiple SARS-CoV-2 variants of concern

New Astra-Zeneca B.1.351 vaccine AZD2816 strongly immunogenic against multiple SARS-CoV-2 variants of concern

Shark vNAR antibodies inhibit SARS-CoV-2 variants in vitro

Shark vNAR antibodies inhibit SARS-CoV-2 variants in vitro

SARS-CoV-2 enzyme inhibitors among drugs screened for repurposing

SARS-CoV-2 enzyme inhibitors among drugs screened for repurposing

NIH researchers identify novel small molecule inhibitors of SARS-CoV-2 variants

NIH researchers identify novel small molecule inhibitors of SARS-CoV-2 variants

Could COVID-19 vaccinations or prior infections protect against other coronaviruses?

Could COVID-19 vaccinations or prior infections protect against other coronaviruses?

Comparison of immunological profiles of SARS-CoV-2 variants

Comparison of immunological profiles of SARS-CoV-2 variants

Two repurposed drugs inhibit SARS-CoV-2 entry factors in a synergistic manner

Two repurposed drugs inhibit SARS-CoV-2 entry factors in a synergistic manner

Researchers find natural metabolites help SARS-CoV-2 escape antibodies

Researchers find natural metabolites help SARS-CoV-2 escape antibodies

Researchers repurpose pre-existing anti-SARS-CoV antibody to develop potent neutralizing antibody against SARS-CoV-2

Researchers repurpose pre-existing anti-SARS-CoV antibody to develop potent neutralizing antibody against SARS-CoV-2

Corilagin: could a plant compound used in Chinese herbal medicine help prevent COVID-19?

Corilagin: could a plant compound used in Chinese herbal medicine help prevent COVID-19?

Discovery of novel SARS-related coronaviruses in bats

Discovery of novel SARS-related coronaviruses in bats

Novel natural compounds may help treat COVID-19, study suggests

Novel natural compounds may help treat COVID-19, study suggests

Computationally designed peptide blocks the entry of SARS-CoV, SARS-CoV-2, and MERS-CoV

Computationally designed peptide blocks the entry of SARS-CoV, SARS-CoV-2, and MERS-CoV

SARS-CoV-2 B.1.1.7 and B.1.351 variants exhibit enhanced affinity towards the ACE2 receptor

SARS-CoV-2 B.1.1.7 and B.1.351 variants exhibit enhanced affinity towards the ACE2 receptor

How do common mutations in SARS-CoV-2’s spike affect its binding affinity with host cell receptors?

How do common mutations in SARS-CoV-2’s spike affect its binding affinity with host cell receptors?

Could graphene oxide nanosheets be an effective SARS-CoV-2 antiviral in PPE?

Could graphene oxide nanosheets be an effective SARS-CoV-2 antiviral in PPE?

Virtual analysis identifies a potential natural inhibitor of SARS-CoV-2 Nsp15

Virtual analysis identifies a potential natural inhibitor of SARS-CoV-2 Nsp15

SARS-CoV-2 B.1.1.420 and B.1.617.1 immune escape variants reported in France

SARS-CoV-2 B.1.1.420 and B.1.617.1 immune escape variants reported in France